{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:55:18Z","timestamp":1790830518230,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073313","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T21:25:14Z","timestamp":1377206714000},"page":"e73313","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines"],"prefix":"10.1371","volume":"8","author":[{"given":"Eric A.","family":"Weaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,22]]},"reference":[{"key":"ref1","article-title":"Influenza Fact Sheet","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"NA Molinari","year":"2007","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1097\/01.inf.0000092193.91306.2f","article-title":"Influenza-related hospitalizations among young children in Leicestershire","volume":"22","author":"KG Nicholson","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1073\/pnas.162366899","article-title":"The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic","volume":"99","author":"ED Kilbourne","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","first-page":"323","article-title":"The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines","volume":"39","author":"CW Potter","year":"1977","journal-title":"Dev Biol Stand"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"ML Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0264-410X(99)00509-5","article-title":"Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly","volume":"18","author":"M Muszkat","year":"2000","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0264-410X(02)00481-4","article-title":"Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine","volume":"21","author":"M Muszkat","year":"2003","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-3527(08)60371-1","article-title":"Influenza vaccines: present and future","volume":"54","author":"K Subbarao","year":"1999","journal-title":"Adv Virus Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00253-004-1874-1","article-title":"Influenza vaccines: recent advances in production technologies","volume":"67","author":"N Bardiya","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref11","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"52","author":"CB Bridges","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/435404a","article-title":"Avian flu special: is this our best shot?","volume":"435","author":"E Check","year":"2005","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/j.vaccine.2005.10.011","article-title":"Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy","volume":"23","author":"R Daems","year":"2005","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1016\/S0264-410X(01)00053-6","article-title":"Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains","volume":"19","author":"JA Tree","year":"2001","journal-title":"Vaccine"},{"key":"ref15","author":"Schuchat"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"MT Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pone.0002975","article-title":"Influence of prior influenza vaccination on antibody and B-cell responses","volume":"3","author":"S Sasaki","year":"2008","journal-title":"PLOS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd1988","article-title":"Influenza vaccines","volume":"5","author":"MJ Belsey","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006454-200301000-00010","article-title":"Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children","volume":"22","author":"DI Bernstein","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/INF.0b013e318256605e","article-title":"Adenovirus respiratory infections in hospitalized children: clinical findings in relation to species and serotypes","volume":"31","author":"I Tabain","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"P Abbink","year":"2007","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/CVI.00173-07","article-title":"Seroprevalence of Neutralizing Antibodies to Adenovirus Type 5 among Children in India: Implications for Recombinant Adenovirus-Based Vaccines","volume":"14","author":"MB Appaiahgari","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1128\/JVI.78.23.13207-13215.2004","article-title":"Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5","volume":"78","author":"L Holterman","year":"2004","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/erv.13.26","article-title":"Progress in the development of an adenovirus 26 vector platform for HIV vaccines","volume":"12","author":"J Esparza","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"DH Barouch","year":"2011","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"TC Mast","year":"2010","journal-title":"Vaccine"},{"key":"ref27","article-title":"H1N1 Preparedness: An Overview of Vaccine Production and Distribution","author":"MDMD Anne Schuchat","year":"2011"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e18314","DOI":"10.1371\/journal.pone.0018314","article-title":"Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin","volume":"6","author":"EA Weaver","year":"2011","journal-title":"PLOS ONE"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2010.10.041","article-title":"Characterization of species C human adenovirus serotype 6 (Ad6)","volume":"412","author":"EA Weaver","year":"2011","journal-title":"Virology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e22605","DOI":"10.1371\/journal.pone.0022605","article-title":"Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza","volume":"6","author":"J Zhang","year":"2011","journal-title":"PLOS ONE"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0042-6822(84)90288-5","article-title":"Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice","volume":"134","author":"AK Gitelman","year":"1984","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/303706a0","article-title":"Evidence for host-cell selection of influenza virus antigenic variants","volume":"303","author":"GC Schild","year":"1983","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2307\/1590681","article-title":"Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A\/Chicken\/Pennsylvania\/1370\/83 infection","volume":"29","author":"JM Wood","year":"1985","journal-title":"Avian Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.1221466","article-title":"Influenza: options to improve pandemic preparation","volume":"336","author":"R Rappuoli","year":"2012","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"S Herfst","year":"2012","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"M Imai","year":"2012","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2012","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"DH Barouch","year":"2010","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.02616-07","article-title":"Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys","volume":"82","author":"J Liu","year":"2008","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"SW Lin","year":"2007","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.4049\/jimmunol.0900317","article-title":"Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens","volume":"182","author":"N Tatsis","year":"2009","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ymthe.2004.03.006","article-title":"Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector","volume":"9","author":"SK Campos","year":"2004","journal-title":"Molecular Therapy"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/hum.2004.15.1125","article-title":"Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombination","volume":"15","author":"SK Campos","year":"2004","journal-title":"Hum Gene Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/JCM.41.11.5046-5052.2003","article-title":"Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors","volume":"41","author":"MC Sprangers","year":"2003","journal-title":"J Clin Microbiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T11:23:59Z","timestamp":1596367439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073313"}},"subtitle":[],"editor":[{"given":"Eliane\u00a0Namie","family":"Miyaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,22]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073313","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,22]]}}}